{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:58:16Z","timestamp":1785153496891,"version":"3.55.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,6,5]],"date-time":"2014-06-05T00:00:00Z","timestamp":1401926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s40272-014-0078-0","type":"journal-article","created":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T22:26:21Z","timestamp":1401920781000},"page":"267-274","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["The Pharmacologic Management of Delirium in Children and Adolescents"],"prefix":"10.1007","volume":"16","author":[{"given":"Susan Beckwitt","family":"Turkel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Hanft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,5]]},"reference":[{"key":"78_CR1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/0021-9681(59)90165-1","volume":"9","author":"GL Engel","year":"1959","unstructured":"Engel GL, Romano J. Delirium, a syndrome of cerebral insufficiency. J Chronic Dis. 1959;9:260\u201377.","journal-title":"J Chronic Dis"},{"key":"78_CR2","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/archneurpsyc.1944.02290280054003","volume":"51","author":"J Romano","year":"1944","unstructured":"Romano J, Engel GL. Delirium I. Electroencephalographic data. Arch Neurol Psychiatr. 1944;51:356\u201377.","journal-title":"Arch Neurol Psychiatr"},{"key":"78_CR3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1176\/ajp.153.2.231","volume":"153","author":"W Breitbart","year":"1996","unstructured":"Breitbart W, Marotta R, Platt MM, Weisman H, Derevenco M, Grau C, Corbera K, Raymond S, Lund S, Jacobsen P. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatr. 1996;153:231\u20137.","journal-title":"Am J Psychiatr"},{"issue":"5","key":"78_CR4","first-page":"1","volume":"156","author":"PT Trzepacz","year":"1999","unstructured":"Trzepacz PT, Breitbart W, Levenson J, Franklin J, Martini DR. Practice guideline for the treatment of patients with delirium. Am J Psychiatr. 1999;156(5):1\u201320.","journal-title":"Am J Psychiatr"},{"key":"78_CR5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/000992280204100111","volume":"41","author":"AM Harrison","year":"2002","unstructured":"Harrison AM, Lugo RA, Lee EW, Appachi E, Bourdakos D, Davis SJ, McHugh MJ, Weise KL. The use of haloperidol in agitated critically ill children. Clin Pediatr. 2002;41:51\u20134.","journal-title":"Clin Pediatr"},{"key":"78_CR6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ejim.2012.06.010","volume":"23","author":"A Deksnyt\u0117","year":"2012","unstructured":"Deksnyt\u0117 A, Aranauskas R, Budrys V, Kasieulevic\u0117 V, \u015capoka V. Delirium: its historical evolution and current interpretation. Eur J Int Med. 2012;23:483\u20136.","journal-title":"Eur J Int Med"},{"key":"78_CR7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00787-009-0063-2","volume":"19","author":"IAP Smeets","year":"2010","unstructured":"Smeets IAP, Tan EYL, Vossen HGM, Leroy PLJM, Lousberg RHB, van Os J, Schieveld JNM. Prolonged stay at the pediatric intensive care unit associated with pediatric delirium. Eur Child Adolesc Psychiatr. 2010;19:389\u201393.","journal-title":"Eur Child Adolesc Psychiatr"},{"key":"78_CR8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.amjmed.2005.05.033","volume":"119","author":"SJ Eisendrath","year":"2006","unstructured":"Eisendrath SJ, Shim JJ. Management of psychiatric problems in critically ill patients. Am J Med. 2006;119:22\u20139.","journal-title":"Am J Med"},{"key":"78_CR9","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1345\/aph.1H241","volume":"40","author":"H Lacasse","year":"2006","unstructured":"Lacasse H, Perreault MM, Williamson DR. Systemic review of antipsychotics for the treatment of hospital associated delirium in medically and surgically ill patients. Ann Pharmacother. 2006;40:1966\u201373.","journal-title":"Ann Pharmacother"},{"key":"78_CR10","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00006842-198001001-00012","volume":"42 suppl","author":"DC Prugh","year":"1980","unstructured":"Prugh DC, Wagonfield S, Metcalf D, Jordan K. A clinical study of delirium in children and adolescents. Psychosom Med. 1980;42 suppl:177\u201395.","journal-title":"Psychosom Med"},{"key":"78_CR11","first-page":"A5477","volume":"179","author":"TD Girard","year":"2009","unstructured":"Girard TD, Jackson JC, Pandharipande PP, Thompson JL, Shintani AK, Ely EW. Duration of delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Am J Respir Crit Care Med. 2009;179:A5477.","journal-title":"Am J Respir Crit Care Med"},{"key":"78_CR12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jpsychores.2009.10.011","volume":"68","author":"S Hatherill","year":"2010","unstructured":"Hatherill S, Flisher AJ. Delirium in children and adolescents: a systematic review of the literature. J Psychosom Res. 2010;68:337\u201344.","journal-title":"J Psychosom Res"},{"key":"78_CR13","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4065\/70.10.989","volume":"70","author":"TA Rummans","year":"1995","unstructured":"Rummans TA, Evans JM, Krahn LE, Fleming KC. Delirium in elderly patients: evaluation and management. Mayo Clin Proc. 1995;70:989\u201398.","journal-title":"Mayo Clin Proc"},{"key":"78_CR14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jpsychores.2006.11.013","volume":"62","author":"SE Rooij de","year":"2007","unstructured":"de Rooij SE, van Munster BC, Korevaar JC, Levi M. Cytokines and acute phase response in delirium. J Psychosom Res. 2007;62:521\u20135.","journal-title":"J Psychosom Res"},{"key":"78_CR15","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ccc.2008.06.004","volume":"24","author":"JR Maldonado","year":"2008","unstructured":"Maldonado JR. Pathoetiological model of delirium: a comprehensive understanding of the neurobiology of delirium and an evidence-based approach to prevention and treatment. Crit Care Clin. 2008;24:789\u2013856.","journal-title":"Crit Care Clin"},{"key":"78_CR16","doi-asserted-by":"crossref","unstructured":"Rudolph JL, Ramlawi B, Kuchel GA, McElhaney JE, Xie D, Sellke FW, Khabbaz K, Levkoff SE, Marcantonio ER. Chemokines are associated with delirium after cardiac surgery. J Gerontol A Biol Med Sci. 2008;63:184\u20139.","DOI":"10.1093\/gerona\/63.2.184"},{"key":"78_CR17","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1176\/appi.ajp.2010.09111606","volume":"167","author":"GH Silver","year":"2010","unstructured":"Silver GH, Kearney JA, Kutko MC, Bartell AS. Infant delirium in pediatric critical care settings. Am J Psychiatr. 2010;167:1172\u20137.","journal-title":"Am J Psychiatr"},{"key":"78_CR18","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000017167","volume":"10","author":"L Tune","year":"1999","unstructured":"Tune L, Egeli S. Acetylcholine and delirium. Dement Geriatr Cogn Disord. 1999;10:342\u20134.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"78_CR19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1532-5415.2011.03883.x","volume":"60","author":"J Cerejeira","year":"2012","unstructured":"Cerejeira J, Nogueira V, Luis P, Vaz-Serra A, Mukaetova-Ladinska EB. The cholinergic system and inflammation: common pathways in delirium pathophysiology. J Am Geriatr Soc. 2012;60:669\u201375.","journal-title":"J Am Geriatr Soc"},{"key":"78_CR20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0022-3956(02)00006-7","volume":"36","author":"P Eikelenboom","year":"2002","unstructured":"Eikelenboom P, Hoogendijk WJG, Jonker C, van Tilburg W. Immunologic mechanisms and the spectrum of psychiatric syndromes in Alzheimer\u2019s disease. J Psychiatr Res. 2002;36:269\u201380.","journal-title":"J Psychiatr Res"},{"key":"78_CR21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1176\/appi.psy.47.1.56","volume":"47","author":"JS Seaman","year":"2006","unstructured":"Seaman JS, Schillerstrom J, Carroll D, Brown TM. Impaired oxidative metabolism precipitates delirium: a study of 101 ICU patients. Psychosomatics. 2006;47:56\u201361.","journal-title":"Psychosomatics"},{"key":"78_CR22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jpsychores.2008.05.019","volume":"65","author":"AMJ MacLullich","year":"2008","unstructured":"MacLullich AMJ, Ferguson KJ, Miller T, de Rooij SEJA, Cunningham C. Unravelling the pathophysiology of delirium: a focus on the role of aberrant stress response. J Psychosom Res. 2008;65:229\u201338.","journal-title":"J Psychosom Res"},{"key":"78_CR23","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1176\/ajp.149.10.1393","volume":"149","author":"L Tune","year":"1992","unstructured":"Tune L, Carr S, Hoag E, Cooper T. Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium. Am J Psychiatr. 1992;149:1393\u20134.","journal-title":"Am J Psychiatr"},{"key":"78_CR24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ccc.2012.10.007","volume":"29","author":"NE Brummel","year":"2013","unstructured":"Brummel NE, Girard TD. Preventing delirium in the intensive care unit. Crit Care Clin. 2013;29:51\u201365.","journal-title":"Crit Care Clin"},{"key":"78_CR25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/ageing\/afq140","volume":"40","author":"A Clegg","year":"2011","unstructured":"Clegg A, Young JB. Which medications to avoid in people at risk of delirium: a systematic review. Age Aging. 2011;40:23\u20139.","journal-title":"Age Aging"},{"key":"78_CR26","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.chc.2006.02.005","volume":"15","author":"FJ Stoddard","year":"2006","unstructured":"Stoddard FJ, Usher CT, Abrams AN. Psychopharmacology in pediatric critical care. Child Adolesc Clin North Am. 2006;15:611\u201355.","journal-title":"Child Adolesc Clin North Am"},{"key":"78_CR27","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1378\/chest.114.2.541","volume":"114","author":"MH Kollef","year":"1998","unstructured":"Kollef MH, Levy NT, Ahrens TS, Schaiff R, Prentice D, Sherman G. The use of continuous IV sedation is associated with prolongation of mechanical ventilation. Chest. 1998;114:541\u20138.","journal-title":"Chest"},{"key":"78_CR28","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1097\/00003246-200006000-00079","volume":"28","author":"JD Tobias","year":"2000","unstructured":"Tobias JD. Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit. Crit Care Med. 2000;28:2122\u201332.","journal-title":"Crit Care Med"},{"key":"78_CR29","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1007\/s00134-010-1989-z","volume":"36","author":"JN Schieveld","year":"2010","unstructured":"Schieveld JN, Staal M, Voogd L, Fioncken J, Vos G, van Os J. Refractory agitation as a marker for pediatric delirium in very young infants in the intensive care unit. Intensive Care Med. 2010;36:1982\u20133.","journal-title":"Intensive Care Med"},{"key":"78_CR30","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.3109\/02699052.2010.498008","volume":"24","author":"J Kean","year":"2010","unstructured":"Kean J, Trzepacz PT, Murray LL, Abell M, Trexler L. Initial validation of a brief provisional diagnostic scale for delirium. Brain Injury. 2010;24:1222\u201330.","journal-title":"Brain Injury"},{"key":"78_CR31","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890423349","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, revised (DSM-TR-IV)","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, revised (DSM-TR-IV). Washington, DC: American Psychiatric Press; 2000."},{"key":"78_CR32","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Washington, DC: American Psychiatric Press; 2013."},{"key":"78_CR33","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1176\/appi.psy.47.4.320","volume":"47","author":"SB Turkel","year":"2006","unstructured":"Turkel SB, Trzepacz PT, Tavare CJ. Comparing symptoms of delirium in adults and children. Psychosomatics. 2006;47:320\u20134.","journal-title":"Psychosomatics"},{"key":"78_CR34","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.genhosppsych.2012.03.003","volume":"34","author":"S Grover","year":"2012","unstructured":"Grover S, Kate N, Malhotra S, Chakrabarti S, Mattoo SK, Avasthi A. Symptom profile of delirium in children and adolescent\u2014does it differ from adults and elderly? Gen Hosp Psychiatr. 2012;34:626\u201332.","journal-title":"Gen Hosp Psychiatr"},{"key":"78_CR35","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jpsychores.2007.11.003","volume":"64","author":"AFG Leentjens","year":"2008","unstructured":"Leentjens AFG, Schieveld JNM, Leonard M, Lousberg R, Verhey FRJ, Meagher DJ. A comparison of the phenomenology of pediatric, adult, and geriatric delirium. J Psychosom Res. 2008;64:219\u201323.","journal-title":"J Psychosom Res"},{"key":"78_CR36","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1176\/appi.neuropsych.15.4.431","volume":"15","author":"SB Turkel","year":"2003","unstructured":"Turkel SB, Tavare CJ. Delirium in children and adolescents. J Neuropsychiatr Clin Neurosci. 2003;15:431\u20135.","journal-title":"J Neuropsychiatr Clin Neurosci"},{"key":"78_CR37","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1089\/cap.2013.0001","volume":"25","author":"SB Turkel","year":"2013","unstructured":"Turkel SB, Jacobson J, Tavar\u00e9 CJ. The diagnosis and management of delirium in infancy. J Child Adolesc Psychopharmacol. 2013;25:352\u20136.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"78_CR38","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.earlhumdev.2004.05.006","volume":"80","author":"D Holditch-Davis","year":"2004","unstructured":"Holditch-Davis D, Scher M, Schwartz T, Hudson-Barr D. Sleeping and waking state development in preterm infants. Early Hum Dev. 2004;80:43\u201364.","journal-title":"Early Hum Dev"},{"key":"78_CR39","unstructured":"Meagher DJ, O\u2019Hanlon D, O\u2019Mahoney E, Casey PR, Trzepacz PT. Relationship between symptoms and motoric subtype of delirium."},{"key":"78_CR40","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0033-3182(96)71517-7","volume":"37","author":"RP Hart","year":"1996","unstructured":"Hart RP, Levenson JL, Sessler CN, Best AM, Schwartz SM, Rutherford LE. Validation of a cognitive test for delirium in medical intensive care patients. Psychosomatics. 1996;37:533\u201346.","journal-title":"Psychosomatics"},{"key":"78_CR41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.genhosppsych.2013.10.005","volume":"36","author":"S Grover","year":"2014","unstructured":"Grover S, Ghosh A, Kate N, Malhotra S, Mattoo SK, Chakrabarti S, Avasthi A. Do motor subtypes of delirium in child and adolescent have a different clinical and phenomenologic profile? Gen Hosp Psychiatry. 2014;36:187\u201391.","journal-title":"Gen Hosp Psychiatry"},{"key":"78_CR42","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/089198879801100304","volume":"11","author":"RC Mast van der","year":"1998","unstructured":"van der Mast RC. Pathophysiology of delirium. J Geriatr Psychiatr Neurol. 1998;11:138\u201345.","journal-title":"J Geriatr Psychiatr Neurol"},{"key":"78_CR43","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/14656566.7.5.555","volume":"7","author":"JB Grace","year":"2006","unstructured":"Grace JB, Holmes J. The management of behavioural and psychiatric symptoms in delirium. Expert Opin Pharmacother. 2006;7:555\u201361.","journal-title":"Expert Opin Pharmacother"},{"key":"78_CR44","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1192\/bjp.168.4.512","volume":"168","author":"DJ Meagher","year":"1996","unstructured":"Meagher DJ, O\u2019Hanlon D, O\u2019Mahony E, Casey PR. The use of environmental strategies and psychotropic medication in the management of delirium. Br J Psychiatry. 1996;168:512\u20135.","journal-title":"Br J Psychiatry"},{"key":"78_CR45","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.chi.0000153716.52154.cf","volume":"44","author":"DR Martini","year":"2005","unstructured":"Martini DR. Commentary: the diagnosis of delirium in pediatric patients. J Am Acad Child Adolesc Psychiatry. 2005;44:395\u20138.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"78_CR46","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00134-007-0637-8","volume":"33","author":"JN Schieveld","year":"2009","unstructured":"Schieveld JN, Leeroy PL, van Os J, Nicolai J, Vos GD, Leentjens AP. Pediatric delirium in critical illness: phenomenology, clinical correlates and treatment response in 40 cases in the pediatric intensive care unit. Intensive Care Med. 2009;33:1033\u201340.","journal-title":"Intensive Care Med"},{"key":"78_CR47","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jpsychores.2008.05.025","volume":"65","author":"RS Bourne","year":"2008","unstructured":"Bourne RS, Tahir TA, Borthwick M, Sampson EL. Drug treatment of delirium: past, present and future. J Psychosom Res. 2008;65:273\u201382.","journal-title":"J Psychosom Res"},{"key":"78_CR48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bpa.2012.07.005","volume":"26","author":"JW Devlin","year":"2012","unstructured":"Devlin JW, Al-Qadhee NS, Skrobik Y. Pharmacologic prevention and treatment of delirium in critically ill and non-critically ill hospitalized patients: a review of data from prospective, randomized studies. Best Pract Res Clin Anaesthesiol. 2012;26:289\u2013309.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"78_CR49","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ccc.2008.05.008","volume":"24","author":"JR Maldonado","year":"2008","unstructured":"Maldonado JR. Delirium in the acute care setting: characteristics, diagnosis, and treatment. Crit Care Clin. 2008;24:657\u2013722.","journal-title":"Crit Care Clin"},{"key":"78_CR50","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/CHI.0b13e3181908bf4","volume":"48","author":"DR DeMaso","year":"2009","unstructured":"DeMaso DR, Martini DR, Cahen LA, Bukstein O, Walter HJ, Benson S, Chrisman A, Farchione T, Hamilton J, Keable H, Kinlan J, Schoettle U, Siegel M, Stock S, Ptakowski KK, Medicus J, Work Group on Quality Issues. Practice parameter for the psychiatric assessment and management of physically ill children and adolescents. J Am Acad Child Adolesc Psychiatry. 2009;48:213\u201333.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"78_CR51","first-page":"240","volume":"13","author":"H-J Yoon","year":"2013","unstructured":"Yoon H-J, Park K-M, Choi W-J, Choi S-H, Park J-Y, Kim J-J, Seok J-H. Efficacy and safety of haloperidol versus atypical antipsychotic medications in the treatment of delirium. Br Med J Psychiatry. 2013;13:240\u201351.","journal-title":"Br Med J Psychiatry"},{"key":"78_CR52","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ccc.2009.05.002","volume":"25","author":"HB Smith","year":"2009","unstructured":"Smith HB, Fuchs DC, Pandharipande PP, Barr FE, Ely EW. Delirium: an emerging frontier in the management of critically ill children. Crit Care Clin. 2009;25:593\u2013614.","journal-title":"Crit Care Clin"},{"key":"78_CR53","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.pcl.2013.02.010","volume":"60","author":"HAB Smith","year":"2013","unstructured":"Smith HAB, Brink E, Fuchs DC, Ely EW, Pandharipande PP. Pediatric delirium: monitoring and management in the pediatric intensive care unit. Pediatr Clin North Am. 2013;60:741\u201360.","journal-title":"Pediatr Clin North Am"},{"key":"78_CR54","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1089\/cap.2011.0084","volume":"22","author":"SB Turkel","year":"2012","unstructured":"Turkel SB, Jacobson JR, Munzig E, Tavar\u00e9 CJ. Atypical antipsychotic medications to control symptoms of delirium in children and adolescents. J Child Adolesc Psychopharmacol. 2012;22:126\u201330.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"78_CR55","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2147\/DDDT.S45575","volume":"7","author":"B Maneeton","year":"2013","unstructured":"Maneeton B, Maneeton N, Srisurapanont M, Chittawatanarat K. Quetiapine versus haloperidol in the treatment of delirium: a double-blind, randomized, controlled trial. Drug Design Dev Ther. 2013;7:657\u201367.","journal-title":"Drug Design Dev Ther"},{"key":"78_CR56","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jpsychores.2010.05.006","volume":"69","author":"TA Tahir","year":"2010","unstructured":"Tahir TA, Eeles E, Karapareddy V, Muthuvelu P, Chappie S, Phillips B, Adyemo T, Farewell D, Bisson JI. A randomized controlled trial of quetiapine versus placebo in the treatment of delirium. J Psychosom Res. 2010;69:485\u201390.","journal-title":"J Psychosom Res"},{"key":"78_CR57","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jpsychores.2011.01.019","volume":"71","author":"S Grover","year":"2011","unstructured":"Grover S, Kumar V, Chakrabarti S. Comparative efficacy study of haloperidol, olanzapine, and risperidone in delirium. J Psychosom Res. 2011;71:277\u201381.","journal-title":"J Psychosom Res"},{"issue":"3","key":"78_CR58","first-page":"121","volume":"2","author":"C Traube","year":"2013","unstructured":"Traube C, Witcher R, Mendez-Rico E, Silver G. Quetiapine as treatment for delirium in critically ill children: a case report. J Pediatr Intensive Care. 2013;2(3):121\u20136.","journal-title":"J Pediatr Intensive Care"},{"key":"78_CR59","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/bmj.322.7279.144","volume":"322","author":"DJ Meagher","year":"2001","unstructured":"Meagher DJ. Delirium: optimizing management. Br Med J. 2001;322:144\u20139.","journal-title":"Br Med J"},{"issue":"12 Suppl","key":"78_CR60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.ccm.0000425128.21038.96","volume":"40","author":"V Sloof","year":"2012","unstructured":"Sloof V. Adverse events of haloperidol for the treatment of delirium in critically ill children. Crit Care Med. 2012;40(12 Suppl):1\u2013338.","journal-title":"Crit Care Med"},{"key":"78_CR61","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1017\/S1478951505050352","volume":"3","author":"S Boettger","year":"2005","unstructured":"Boettger S, Breitbart W. Atypical antipsychotics in the management of delirium: a review of the empirical literature. Palliat Support Care. 2005;3:227\u201337.","journal-title":"Palliat Support Care"},{"key":"78_CR62","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jpsychores.2006.10.004","volume":"62","author":"L Michaud","year":"2007","unstructured":"Michaud L, Bula C, Berney A, Camus V, Voellinger R, Stiefel F, Burnand B, Delirium Guidelines Development Group. Delirium: guidelines for general hospitals. J Psychosom Res. 2007;62:371\u201383.","journal-title":"J Psychosom Res"},{"key":"78_CR63","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1017\/S1478951508000266","volume":"6","author":"Y Alici-Evcimen","year":"2008","unstructured":"Alici-Evcimen Y, Breitbart W. An update on the use of antipsychotics in the treatment of delirium. Palliat Support Care. 2008;6:177\u201382.","journal-title":"Palliat Support Care"},{"issue":"1","key":"78_CR64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11538550-000000000-00000","volume":"13","author":"L Sonnier","year":"2011","unstructured":"Sonnier L, Barzman D. Pharmacologic management of acutely agitated pediatric patients. Pediatr Drugs. 2011;13(1):1\u201310.","journal-title":"Pediatr Drugs"},{"key":"78_CR65","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJM199907293410512","volume":"341","author":"CE Schwartz","year":"1999","unstructured":"Schwartz CE. Delirium in hospitalized older patients. N Engl J Med. 1999;341:369\u201370.","journal-title":"N Engl J Med"},{"key":"78_CR66","first-page":"49","volume":"2","author":"S Sassano-Higgins","year":"2013","unstructured":"Sassano-Higgins S, Freudenberg N, Jacobson J, Turkel S. Olanzapine reduces delirium symptoms in the critically ill pediatric patient. J Pediatr Intensive Care. 2013;2:49\u201354.","journal-title":"J Pediatr Intensive Care"},{"key":"78_CR67","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/j.jad.2012.02.030","volume":"138","author":"L Ben-Amor","year":"2012","unstructured":"Ben-Amor L. Antipsychotics in pediatric and adolescent patients: a review of comparative safety data. J Affect Disord. 2012;138:S22\u201350.","journal-title":"J Affect Disord"},{"key":"78_CR68","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s00482-013-1293-2","volume":"27","author":"KM Perrar","year":"2013","unstructured":"Perrar KM, Golla H, Voltz R. Pharmacological treatment of delirium in palliative care patients. Der Schmerz. 2013;27:190\u20138.","journal-title":"Der Schmerz"},{"issue":"2","key":"78_CR69","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1176\/appi.ajp.2013.13040458","volume":"171","author":"JI Friedman","year":"2014","unstructured":"Friedman JI, Soleimani L, McGonigle DP, Egol C, Silverstein JH. Pharmacological treatments of non-substance-withdrawal delirium: a systematic review of prospective trials. Am J Psychiatry. 2014;171(2):151\u20139.","journal-title":"Am J Psychiatry"},{"key":"78_CR70","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1176\/appi.psy.50.1.8","volume":"50","author":"DP Seitz","year":"2009","unstructured":"Seitz DP, Gill SS. Neuroleptic malignant syndrome complicating antipsychotic treatment of delirium or agitation in medical and surgical patients: case reports and a review of the literature. Psychosomatics. 2009;50:8\u201315.","journal-title":"Psychosomatics"},{"key":"78_CR71","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jemermed.2012.03.002","volume":"43","author":"AB Minns","year":"2012","unstructured":"Minns AB, Clark RF. Toxicology and overdose of atypical antipsychotics. J Emerg Med. 2012;43:906\u201313.","journal-title":"J Emerg Med"},{"key":"78_CR72","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","volume":"8","author":"M Hert De","year":"2012","unstructured":"De Hert M, Detraux J, van Winkel R, Yu W, Correll CU. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nature Rev Endocrinol. 2012;8:114\u201326.","journal-title":"Nature Rev Endocrinol"},{"issue":"1","key":"78_CR73","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/chi.0b013e31815b5cb1","volume":"47","author":"CU Correll","year":"2008","unstructured":"Correll CU, Kratochvil CJ. Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes. J Am Acad Child Adolesc Psychiatry. 2008;47(1):9\u201320.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"78_CR74","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa0806994","volume":"360","author":"WA Ray","year":"2009","unstructured":"Ray WA, Chung CP, Murray KT, Hall K, Stein CM. Atypical antipsychotic drugs and the risk of sudden cardiac death. N Engl J Med. 2009;360:225\u201335.","journal-title":"N Engl J Med"},{"key":"78_CR75","first-page":"1","volume":"Suppl 10","author":"CE Leonard","year":"2013","unstructured":"Leonard CE, Freeman CP, Newcomb CW, Bilker WB, Kimmel SE, Strom BL, Hennessy S. Antipsychotics and the risks of sudden cardiac death and all-cause death: cohort studies in Medicaid and dually-eligible Medicaid-Medicare beneficiaries of five states. J Clin Exp Cardiol. 2013;Suppl 10:1\u20139.","journal-title":"J Clin Exp Cardiol"},{"key":"78_CR76","first-page":"36","volume":"11","author":"NB Washington","year":"2012","unstructured":"Washington NB, Brahm NC, Kissack J. Which psychotropic carry the greatest risk of QTc prolongation? Curr Psychiatr. 2012;11:36\u20139.","journal-title":"Curr Psychiatr"},{"key":"78_CR77","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00004714-200104000-00014","volume":"31","author":"I Gaertner","year":"2001","unstructured":"Gaertner I, Altendorf K, Batra A, Gaertner HJ. Relevance of liver enzyme elevations with four different neuroleptics: a retrospective review of 7263 treatment courses. J Clin Psychopharmacol. 2001;31:215\u201322.","journal-title":"J Clin Psychopharmacol"},{"key":"78_CR78","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.pnpbp.2007.05.005","volume":"31","author":"N Atasoy","year":"2007","unstructured":"Atasoy N, Erdogan A, Yalug I, Ozturk U, Konuk N, Atik L, Ustundag Y. A review of liver function tests during treatment with atypical antipsychotic drugs: a chart review study. Prog Neuro Psychopharm Biol Psychiatry. 2007;31:1255\u201360.","journal-title":"Prog Neuro Psychopharm Biol Psychiatry"},{"key":"78_CR79","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/cap.1999.9.93","volume":"9","author":"E Szigethy","year":"1999","unstructured":"Szigethy E, Wiznitzer M, Branicky LA, Maxwell K, Findling RL. Ripseridone-induced hepatotoxicity in children and adolescents? A chart review study. J Child Adolesc Psychopharmacol. 1999;9:93\u20138.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"78_CR80","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/gps.2220","volume":"24","author":"N Tabet","year":"2009","unstructured":"Tabet N, Howard R. Pharmacological treatment for the prevention of delirium: review of current evidence. Int J Geriatr Psychiatry. 2009;24:1037\u201344.","journal-title":"Int J Geriatr Psychiatry"},{"key":"78_CR81","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.0001-5172.2004.00401.x","volume":"48","author":"K Olofsson","year":"2004","unstructured":"Olofsson K, Alling C, Lundberg D, Malmros C. Abolished circadian rhythm of melatonin secretion in sedated and artificially ventilated intensive care patients. Acta Anaesthesiol Scand. 2004;48:679\u201384.","journal-title":"Acta Anaesthesiol Scand"},{"key":"78_CR82","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/bja\/aes035","volume":"108","author":"J Bellaport","year":"2012","unstructured":"Bellaport J, Boots R. Potential use of melatonin in sleep and delirium in the critically ill. Br J Anaesth. 2012;108:572\u201380.","journal-title":"Br J Anaesth"},{"key":"78_CR83","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/gps.2582","volume":"26","author":"T Al-Aama","year":"2011","unstructured":"Al-Aama T, Brymer C, Gutmanis I, Woolmore-Goodwin SM, Esbaugh J, Dasgupta M. Melatonin decreases delirium in elderly patients: a randomized, placebo controlled trial. Int J Geriatr Psychiatry. 2011;26:687\u201394.","journal-title":"Int J Geriatr Psychiatry"},{"key":"78_CR84","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1479-8301.2012.00422.x","volume":"12","author":"M Furuya","year":"2012","unstructured":"Furuya M, Miyaoka T, Yasuda H, Yamashita S, Tanaka I, Otsuka S, Wake R, Horiguchi J. Marked improvement in delirium with ramelteon: five case reports. Psychogeriatrics. 2012;12:259\u201362.","journal-title":"Psychogeriatrics"},{"key":"78_CR85","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/ALN.0b013e3181a91870","volume":"111","author":"ZN Kain","year":"2009","unstructured":"Kain ZN, MacLaren JE, Herrmann L, Mayes L, Rosenbaum A, Hata J, Lerman J. Preoperative melatonin and its effects on induction and emergence in children undergoing anesthesia and surgery. Anesthesiology. 2009;111:44\u20139.","journal-title":"Anesthesiology"},{"key":"78_CR86","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2165\/11207190-000000000-00000","volume":"71","author":"SM Hoy","year":"2011","unstructured":"Hoy SM, Keating GM. Dexmedetomidine: a review of its use for sedation in mechanically ventilated patients in an intensive care setting and for procedural sedation. Drugs. 2011;71:1481\u2013501.","journal-title":"Drugs"},{"key":"78_CR87","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/j.1460-9592.2005.01660.x","volume":"15","author":"M Shukry","year":"2005","unstructured":"Shukry M, Clyde MC, Kalarickal PI, Ramadhyani U. Does dexmedetomidine prevent emergency delirium in children after sevoflurane-based general anesthesia? Pediatr Anesth. 2005;15:1098\u2013104.","journal-title":"Pediatr Anesth"},{"key":"78_CR88","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00246-011-0092-8","volume":"32","author":"JD Tobias","year":"2011","unstructured":"Tobias JD, Gupta P, Naguib A. Dexmedetomidine: applications for the pediatric patient with congenital heart disease. Pediatr Cardiol. 2011;32:1075\u201387.","journal-title":"Pediatr Cardiol"},{"issue":"1","key":"78_CR89","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1592\/phco.28.1.51","volume":"28","author":"ML Buck","year":"2008","unstructured":"Buck ML, Willson DF. Use of dexmedetomidine in the pediatric intensive care unit. Pharmacotherapy. 2008;28(1):51\u20137.","journal-title":"Pharmacotherapy"},{"issue":"5","key":"78_CR90","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1213\/ANE.0b013e31822b8629","volume":"113","author":"KP Mason","year":"2011","unstructured":"Mason KP, Lerman J. Dexmedetomidine in children: current knowledge and future applications. Anesth Analg. 2011;113(5):1129\u201342.","journal-title":"Anesth Analg"},{"issue":"1","key":"78_CR91","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/00148581-200810010-00006","volume":"10","author":"H Phan","year":"2008","unstructured":"Phan H, Nahata MC. Clinical uses of dexmedetomidine in pediatric patients. Pediatr Drugs. 2008;10(1):49\u201369.","journal-title":"Pediatr Drugs"},{"key":"78_CR92","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1345\/aph.1M161","volume":"43","author":"BL Honey","year":"2009","unstructured":"Honey BL, Benefield RJ, Miller JL, Johnson PN. \u03b12-Receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients. Ann Pharmacother. 2009;43:1056\u2013511.","journal-title":"Ann Pharmacother"},{"issue":"pt 2","key":"78_CR93","doi-asserted-by":"crossref","first-page":"8S","DOI":"10.1592\/phco.2005.25.5_Part_2.8S","volume":"25","author":"RR Riker","year":"2005","unstructured":"Riker RR, Fraser GL. Adverse events associated with sedatives, analgesics, and other drugs that provide patient comfort in the intensive care unit. Pharmacotherapy. 2005;25(pt 2):8S\u201318S.","journal-title":"Pharmacotherapy"},{"key":"78_CR94","first-page":"298","volume":"45","author":"M Resnick","year":"1984","unstructured":"Resnick M, Burton BT. Droperidol vs haloperidol in the initial management of acutely agitated patients. J Clin Psychiatry. 1984;45:298\u20139.","journal-title":"J Clin Psychiatry"},{"issue":"Pt 2","key":"78_CR95","doi-asserted-by":"crossref","first-page":"35S","DOI":"10.1592\/phco.30.pt2.35S","volume":"6","author":"BA Bourcher","year":"2010","unstructured":"Bourcher BA. Formulary decisions: then and now. Pharmacotherapy. 2010;6(Pt 2):35S\u201341S.","journal-title":"Pharmacotherapy"},{"key":"78_CR96","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0033-3182(98)71357-X","volume":"39","author":"JM Bostwick","year":"1998","unstructured":"Bostwick JM, Masterson BJ. Psychopharmacological treatment of delirium to restore mental capacity. Psychosomatics. 1998;39:112\u20137.","journal-title":"Psychosomatics"},{"key":"78_CR97","first-page":"765","volume":"30","author":"GK Shaw","year":"1995","unstructured":"Shaw GK. Detoxification: the use of benzodiazepines. Alcohol Alcohol. 1995;30:765\u201370.","journal-title":"Alcohol Alcohol"},{"key":"78_CR98","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.pnpbp.2007.09.021","volume":"32","author":"L Leggio","year":"2008","unstructured":"Leggio L, Kenna GA, Swift RM. New developments for the pharmacological treatment of alcohol withdrawal syndrome: a focus on non-benzodiazepine GABA-ergic medications. Prog Neuro Psychopharmacol Biol Psychiatry. 2008;32:1106\u201317.","journal-title":"Prog Neuro Psychopharmacol Biol Psychiatry"},{"key":"78_CR99","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3928\/0048-5713-20000401-11","volume":"30","author":"R Shaner","year":"2000","unstructured":"Shaner R. Benzodiazepines in psychiatric emergency settings. Psychiatr Ann. 2000;30:268\u201375.","journal-title":"Psychiatr Ann"},{"key":"78_CR100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00000542-200601000-00005","volume":"104","author":"P Pandharipande","year":"2006","unstructured":"Pandharipande P, Shintani A, Peterson J, Pun BT, Wilkinson GR, Dittus RS, Bernard GR, Ely EW. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology. 2006;104:21\u20136.","journal-title":"Anesthesiology"},{"key":"78_CR101","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40272-013-0024-6","volume":"15","author":"S Caccia","year":"2013","unstructured":"Caccia S. Safety and pharmacokinetics of atypical antipsychotics in children and adolescents. Paediatr Drugs. 2013;15:217\u201333.","journal-title":"Paediatr Drugs"},{"issue":"3","key":"78_CR102","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/j.1875-9114.1997.tb03061.x","volume":"17","author":"KR Lawrence","year":"1997","unstructured":"Lawrence KR, Nasraway SA. Conduction disturbances associated with administration of butyrophenone antipsychotics in the critically ill: a review of the literature. Pharmacotherapy. 1997;17(3):531\u20137.","journal-title":"Pharmacotherapy"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-014-0078-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-014-0078-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-014-0078-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T09:27:43Z","timestamp":1716802063000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-014-0078-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,5]]},"references-count":102,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["78"],"URL":"https:\/\/doi.org\/10.1007\/s40272-014-0078-0","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,5]]}}}